Loading
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Previous close
$1.11
−$0.04 · -3.48%
After-hours
$1.0759
−$0.0341 · -3.07%
Oct 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Day range
Current $1.11
52-week range
Current $1.11
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
43
Fair Value
Sentiment
56
Mixed
Risk
66
High Risk
Momentum
16
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Day range
Current $1.11
52-week range
Current $1.11
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | 9.81M USD | 9.5M USD | 4.7M USD | 1.97M USD | 1.81M USD |
| Selling, general, and administrative | 6.28M USD | 5.05M USD | 2.4M USD | 2.45M USD | 2.12M USD |
| Operating expenses | 16.09M USD | 14.55M USD | 7.1M USD | 4.43M USD | 4.04M USD |
| Interest income | — | 62K USD | 7K USD | 11K USD | 26K USD |
| Interest expense | — | 628K USD | — | 3K USD | — |
| Depreciation and amortization | 42K USD | 36K USD | 13K USD | 23K USD | 42K USD |
| Operating income | −16.09M USD | −14.55M USD | −7.1M USD | −4.43M USD | −4.04M USD |
| Net income | −19.39M USD | −22.6M USD | −7.1M USD | −4.44M USD | −4.07M USD |
Company facts updated Oct 9, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 31, 2026 | 1:15 | — | — |
Stock split | Jun 16, 2025 | 1:60 | — | — |
Stock split | May 20, 2024 | 1:5 | — | — |
Stock split | Aug 13, 2021 | 1:13 | — | — |
Effective Aug 31, 2026
1:15
Effective Jun 16, 2025
1:60
Effective May 20, 2024
1:5
Effective Aug 13, 2021
1:13
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
